Follow us on:
Breaking News
July 24, 2026
CP Direct: Friday Edition
Breaking News
FederalEquipment_ENL_070326_650x90

The Friday Brief for July 24, 2026: M&A Activity Heating Up

 
The Friday Brief for July 24, 2026: M&A Activity Heating Up

New partnerships are also being announced at a rapid pace in the areas of drug development and manufacturing.
Watch Now >>

Top Headlines

Breaking News
Financial News

BeOne Medicines Plans $300M NJ Expansion, Bringing US Manufacturing Investment Over $1B

The expansion increases BeOne’s production capacity and should add about 120 new full-time jobs.

SPONSOR

Speed Up Your BLA Pathway With Smarter Analytics

Learn how high-throughput characterization tools help biopharma teams accelerate BLA readiness for complex biologics. Free white paper.

Breaking News

Cold Chain Technologies Launches EcoFlex XS Reusable Shipper

The product extends the capabilities of the established EcoFlex range while maintaining the same reusable, sustainability-focused approach.

Breaking News

Schubert to Construct New Headquarters in Charlotte, North Carolina

The new facility will serve as a hub for sales, engineering, service, customer training and final assembly of Schubert packaging machines.

SPONSOR

Payload-Linker Engineering as a Differentiator in ADC Development and Manufacturing

Advances in payload-linker technology have made ADCs a major therapeutic modality, prompting drug developers to strive for greater selectivity and safety in the next wave of ADCs.

Ensera_eNL_07-24-26_650x250

Breaking News
Promotions & Moves

Vir Biotechnology Appoints Brent Sabatini as Interim Principal Financial Officer

The company has initiated a search to identify its next Chief Financial Officer.

Online Exclusives

Inside Biomanufacturing’s Quality Overhaul as Complex Drugs Surge

How today’s manufacturers are filling the growing need for biologics without rushing complex processes in development or quality control.

Featured Resources

Solution Content Center SPOTLIGHT

Eagle Analytical

Eagle is an FDA- and DEA-registered, A2LA ISO 17025-accredited CGMP laboratory providing analytical, microbiological, consulting, and technical services. From our 80,000+ sq. ft. state-of-the-art facility, we support compliance and quality assurance needs from raw materials to finished products.

 

Solution Center SPOTLIGHT

Kindeva

Kindeva Drug Delivery is a global contract development and manufacturing organization focused on drug-device combination products. We develop and manufacture products across a broad range of drug-delivery formats, including pulmonary and nasal, injectable, and transdermal. Our service offerings span early-stage feasibility through commercial scale drug product fill-finish, container closure system manufacturing, and drug-device product assembly. Kindeva serves a global client base from our state-of-the-art manufacturing, research, and development facilities located across the U.S. and U.K.